- Company
- ImmunityBio
- Role
- Founder & CEO
- Est. Net Worth
- $6 Billion
- Stage
- Elite
- Industry
- Healthcare
Patrick Soon-Shiong
Founder & CEO at ImmunityBio
About
Patrick Soon-Shiong is a surgeon and biotech entrepreneur who founded multiple medical companies, including ImmunityBio, focused on next-generation immunotherapies. He previously developed the cancer drug Abraxane and is one of the wealthiest physicians in the world.
Current Company
ImmunityBio — Founder & CEO
The Surgeon-Entrepreneur
Patrick Soon-Shiong is a surgeon, scientist, inventor, and biotech entrepreneur who has built multiple companies at the intersection of medicine, technology, and immunology. Born in South Africa to Chinese immigrant parents, Patrick Soon-Shiong earned his medical degree at the University of the Witwatersrand and completed his surgical training at UCLA. He developed Abraxane, a nanoparticle-based chemotherapy drug, and sold his company Abraxis BioScience to Celgene for $2.9 billion in 2010.
Patrick Soon-Shiong founded ImmunityBio to develop next-generation immunotherapies, including cancer vaccines and cell-based treatments. As Founder and CEO of ImmunityBio, Patrick Soon-Shiong is pursuing a platform approach to immunology that he believes can address multiple cancers and infectious diseases. He is also the owner of the Los Angeles Times and a major philanthropist focused on healthcare access and medical innovation.